International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMA
No abstract is available for this record.
Bibliographic context
- Journal
- Drug and Alcohol Dependence
- Date
- 2025-01-31
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.Farmacja Polska · 2020-09-27PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-10Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-17Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health TreatmentJournal of Psychoactive Drugs · 2025-05-28Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSDJournal of Psychoactive Drugs · 2023-08-30Psilocybin treatment for AUD: Promise in new studyAlcoholism & Drug Abuse Weekly · 2022-10-13Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive AgeDrug and Alcohol Dependence · 2025-01-31Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”Drug Science Policy and Law · 2026-05-31